Hawryluk P. Kent
CIK: 0001673991•President & CEO
OfficerDirector
Primary company: MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent is a corporate insider (President & CEO) at MBX Biosciences, Inc. (MBX) filing SEC Form 4 transactions. 22 transactions across 2 companies, totaling $1,471,603 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Purchase | 18,500 | $28.41 | $526K | 486,777 | 3/13/2026 Filed: 3/13/2026 | Filing → | |
| Exercise | 182,859 | - | - | 129,708 | 10/24/2025 Filed: 10/28/2025 | Filing → | |
| Exercise | 182,859 | $3.25 | $594K | 664,256 | 10/24/2025 Filed: 10/28/2025 | Filing → | |
| Purchase | 20,000 | $13.64 | $273K | 468,277 | 10/20/2025 Filed: 10/21/2025 | Filing → | |
| Purchase | 50,000 | $10.69 | $535K | 448,277 | 2/4/2025 Filed: 2/5/2025 | Filing → | |
| Award | 243,000 | $10.49 | $2.55M | 243,000 | 2/3/2025 Filed: 2/5/2025 | Filing → | |
| Conversion | 970,873 | - | - | 0 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 76,969 | - | - | 0 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 1,396,762 | - | - | 0 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 345,705 | - | - | 0 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 2,015,681 | - | - | 0 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 115,914 | - | - | 398,277 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Conversion | 283,846 | - | - | 481,397 | 9/16/2024 Filed: 9/17/2024 | Filing → | |
| Award | 120,436 | - | - | 120,436 | 9/12/2024 Filed: 9/13/2024 | Filing → | |
Gemphire Therapeutics Inc. GEMP | Award | 10,800 | $0.00 | $0 | 10,800 | 1/29/2018 Filed: 1/30/2018 | Filing → |
Gemphire Therapeutics Inc. GEMP | Purchase | 18,750 | $9.47 | $178K | 18,750 | 3/10/2017 Filed: 3/14/2017 | Filing → |
Gemphire Therapeutics Inc. GEMP | Purchase | 25,000 | $9.47 | $237K | 81,889 | 3/10/2017 Filed: 3/14/2017 | Filing → |
Gemphire Therapeutics Inc. GEMP | Conversion | 150,000 | $0.00 | $0 | 0 | 8/10/2016 Filed: 8/12/2016 | Filing → |
Gemphire Therapeutics Inc. GEMP | Conversion | 7,457 | $0.00 | $0 | 0 | 8/10/2016 Filed: 8/12/2016 | Filing → |
Gemphire Therapeutics Inc. GEMP | Purchase | 25,000 | $10.00 | $250K | 56,889 | 8/10/2016 Filed: 8/12/2016 | Filing → |
Type
Purchase
Shares
18,500
Price
$28.41
Value
$526K
Type
Exercise
Shares
182,859
Price
-
Value
-
Type
Exercise
Shares
182,859
Price
$3.25
Value
$594K
Type
Purchase
Shares
20,000
Price
$13.64
Value
$273K
Type
Purchase
Shares
50,000
Price
$10.69
Value
$535K
Type
Award
Shares
243,000
Price
$10.49
Value
$2.55M
Type
Conversion
Shares
970,873
Price
-
Value
-
Type
Conversion
Shares
76,969
Price
-
Value
-
Type
Conversion
Shares
1,396,762
Price
-
Value
-
Type
Conversion
Shares
345,705
Price
-
Value
-
Type
Conversion
Shares
2,015,681
Price
-
Value
-
Type
Conversion
Shares
115,914
Price
-
Value
-
Type
Conversion
Shares
283,846
Price
-
Value
-
Type
Award
Shares
120,436
Price
-
Value
-
Gemphire Therapeutics Inc.
GEMP
Type
Award
Shares
10,800
Price
$0.00
Value
$0
Gemphire Therapeutics Inc.
GEMP
Type
Purchase
Shares
18,750
Price
$9.47
Value
$178K
Gemphire Therapeutics Inc.
GEMP
Type
Purchase
Shares
25,000
Price
$9.47
Value
$237K
Gemphire Therapeutics Inc.
GEMP
Type
Conversion
Shares
150,000
Price
$0.00
Value
$0
Gemphire Therapeutics Inc.
GEMP
Type
Conversion
Shares
7,457
Price
$0.00
Value
$0
Gemphire Therapeutics Inc.
GEMP
Type
Purchase
Shares
25,000
Price
$10.00
Value
$250K
AI Agent
Try asking...